Study Links GLP-1 Drugs, Metformin to Lower Risk of Certain Cancers

Seeking Alpha15:04 ET

Unpacking the Latest Options Trading Trends in Moderna

Investors with a lot of money to spend have taken a bullish stance on Moderna (NASDAQ:MRNA).And retail traders should know.We noticed this today when the trades showed up on publicly available options

BenzingaJul 5 10:33 ET

AI Has 'The Hallmarks Of An Inflating Bubble,' Warns Veteran Wall Street Investor

Signs are emerging that the market boom surrounding artificial intelligence (AI) might be taking on the characteristics of a bubble.

BenzingaJul 4 21:12 ET

Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today

Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years by 37.68% on an annualized basis producing an average annual return of 50.84%. Currently, Moderna has a market capitalization of

BenzingaJul 4 12:30 ET

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,300 Today

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 10 years by 1.82% on an annualized basis producing an average annual return of 12.66%. Currently, Regeneron Pharmaceut

BenzingaJul 4 11:30 ET

Lilly's New Alzheimer's Drug Could Generate $7.1B in Sales: Analyst

Seeking AlphaJul 3 13:09 ET